Bronchiectasis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Sjogren's Lung Study

  NCT04843345· Stanford University· Updated 9 Nov 2026

  “Change in research staffing”Registry text, quoted unchanged. Source

• Terminated

  A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

  NCT06603246· Genentech, Inc.· Updated 20 Oct 2026

  “Sponsor's Decision”Registry text, quoted unchanged. Source

• Suspended

  A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis

  NCT07547436· Sanofi· Updated 29 Jul 2026

  “The pause is for strategic business reasons to facilitate internal portfolio review. The pause is not due to any concerns with patient safety, with program benefit/risk, or with trial integrity.”Registry text, quoted unchanged. Source

• Terminated

  Diagnosis and Treatment of Patients With Cystic Fibrosis

  NCT00001223· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Updated 4 Feb 2026

  “PI left NIH”Registry text, quoted unchanged. Source

• Terminated

  Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

  NCT03696290· University of Dundee· Updated 12 Jan 2026

  “Poor recruitment”Registry text, quoted unchanged. Source

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Mannkind Corporation· Updated 12 Nov 2025

  “Futility”Registry text, quoted unchanged. Source

• Terminated

  Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

  NCT05006573· AstraZeneca· Updated 20 Jul 2025

  “Due to the decision to stop recruitment early, enrolment into the MAHALE trial was terminated in August 2022; 139 patients were screened and 100 randomised to IP.”Registry text, quoted unchanged. Source

• Suspended

  Feasibility Study of the AffloVest in Bronchiectasis

  NCT04266873· Papworth Hospital NHS Foundation Trust· Updated 31 May 2025

  “Data analysis review of current data”Registry text, quoted unchanged. Source

• Terminated

  A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting

  NCT04017312· Hill-Rom· Updated 21 Aug 2024

  “Data”Registry text, quoted unchanged. Source

• Withdrawn

  Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis

  NCT03737617· University of Edinburgh· Updated 29 Sept 2021

  “Cant obtain IMP”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Natural History of Bronchiectasis

  NCT00943514· National Heart, Lung, and Blood Institute (NHLBI)· Source

• A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Boehringer Ingelheim· Source

• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Boehringer Ingelheim· Source

• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis

  NCT07720375· UCB Biopharma SRL· Source

• N- Acetylcysteine in Airway Clearance in Bronchiectasis

  NCT07293884· Assiut University· Source

• Investigating Novel Strategies in Pediatric Immune Responses and Microbiome Environment: Comprehensive Lung Disease Investigation in Children.

  NCT06746077· Aarhus University Hospital· Source

• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

  NCT07048262· CSL Behring· Source

• Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

  NCT05846230· Boehringer Ingelheim· Source

• A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

  NCT07774403· AstraZeneca· Source

• A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· Sanofi· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.